Searched for
PIRAMAL PHARMA UPSIDE
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...
- Smallcaps & midcaps rally! Firstsource Solutions, Nuvama, Godfrey Phillips, other stocks jump up to 16%Smallcap and midcap stocks outperformed benchmarks on Friday, with select names rallying up to 16% despite broader market weakness. Gains w...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- Vedanta demerger: When will the four new stocks list on NSE, BSE? Here's what investors can expectVedanta’s demerger has left investors awaiting the listing of its four newly carved-out entities, even as the parent stock continues to ris...
- Should you buy the dip? Strategist Anand James shares his weekly stock strategyMarket expert Anand James suggests caution following recent volatility. He notes the Nifty needs to break above 24,140 for a confirmed upsw...
- Exploring the Growth Potential of the Indian Pharmaceutical SectorThe Indian pharmaceutical sector is poised for significant growth, driven by favorable trade agreements and increasing global demand for ge...
- Piramal Pharma shares in focus after US FDA issues six observations for Mumbai facilityPiramal Pharma shares will be in focus after the US FDA's GMP inspection at its Turbhe facility from February 11-17, 2025, resulting in a F...
- Hot Stocks: 3 stocks that may give returns between 19-39%Brokerages recently initiated coverage on Delhivery, Quess Corp, and Piramal Pharma. These stocks are expected to return between 19% and 39...
- Stock To Buy Today: Brokerages initiate coverage on Afcons Infrastructure & Piramal PharmaBrokerage firms are bullish on Afcons Infrastructure, Delhivery, and Piramal Pharma, projecting significant upside potential. Investec, Equ...
- Buy IT stocks on dips; not big on pharma but like specific stocks: Chakri LokapriyaChakri Lokapriya highlights a selective approach toward pharma, favoring Cipla and Piramal for potential gains due to specific catalysts li...
- Stock Radar: 170% rally in a year! Multibagger pharma stock breaks out from 6-week consolidation; time to buy?Piramal Pharma has broken out from a 6-week consolidation on weekly charts, now trading above key moving averages and is positioned to rise...
- Piramal Pharma stock rises over 3%. Here’s whyThe brokerage firm Jefferies assigned buy rating to Piramal Pharma with a target price of Rs 150, implying an upside potential of 20% from ...
- Piramal Pharma shares hit 5% lower circuit after listingEarlier last week, the company obtained a go-ahead from the National Company Law Tribunal (NCLT) for the listing of its equity shares. Furt...
- Piramal Pharma completes 20% stake sale to CarlyleThe transaction values the Pharma Business at an enterprise value of USD 2,775 million (over Rs 20,300 crore) with an upside component of u...
- CCI approves Piramal Pharma and Carlyle Group dealThe transfer of equity will take place through the Group’s special purpose vehicle Curie, a notice of the combination by the regulator said.
- Can pharma business once again turn Ajay Piramal's fortune?The business house controls both the business segments through a listed entity Piramal Enterprises.
- Buy Piramal Healthcare and Federal Bank: Deepak Mohoni"I would not buy Federal Bank and Piramal Healthcare at this very moment if the market starts stabilising today and starts going up again s...
- GAIL gives good breakout; Piramal outperforms other pharma stocks: Devangvisaria.comDevang Visaria, Chief Strategist, Devangvisaria.com in an interview to ET Now said GAIL has given a good breakout and possibly look for odd...
- Jubilant, Hikal drop out of race for Pfizer's Ireland unitAt least two Indian companies, Jubilant Organosys and Hikal Pharma, have dropped out of the race to acquire Pfizer's Ireland unit. However,...
Load More
